Ltd. Kck serves as Executive at AILERON THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Ltd. Kck has executed 9 insider transactions totaling $3.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 1, 2023 involved selling 3,241 shares valued at $28.3K.
Ltd. Kck currently holds 5,593,773 shares of AILERON THERAPEUTICS INC (ALRN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ltd. Kck has been a net buyer of ALRN stock. They have purchased $3.0M and sold $241.0K worth of shares.
Ltd. Kck's most recent insider trade was on Dec 1, 2023, when they sold 3,241 shares at $8.73 per share.
Get notified when new Form 4 filings are submitted
| $8.84 |
| Discretionary |
| Nov 29, 2023 | NPCE | $49.2K | Sale | 5,644 | $8.72 | Discretionary |
| Nov 28, 2023 | NPCE | $41.0K | Sale | 4,681 | $8.75 | Discretionary |
| Nov 27, 2023 | NPCE | $58.2K | Sale | 6,490 | $8.96 | Discretionary |
| Jul 19, 2021 | SGHT | $0 | Conversion | 4,776,232 | $N/A | Discretionary |
| Apr 26, 2021 | NPCE | $0 | Conversion | 5,595,493 | $N/A | Discretionary |
| Jul 5, 2017 | ALRN | $0 | Conversion | 446,817 | $N/A | Discretionary |
| Jul 5, 2017 | ALRN | $3.0M | Purchase | 200,000 | $15.00 | Discretionary |